The battle against drug resistance in lung cancer therapy remains a critical issue in oncology, with resistance mechanisms ...

Design Therapeutics (NASDAQ:DSGN – Get Free Report) is projected to issue its quarterly earnings data before the market opens ...

Researchers have identified a previously unknown bacterial protein, the structure of which is being used in the design of protein nanoparticles for the targeted delivery of anticancer drugs to tumors.